Oncoinvent AS Norway
07.08.2025 - 18:07:37Oncoinvent Announces First Patient Dosed in its Phase 2 Clinical Trial of Radspherin® in Ovarian Cancer Patients
View original content:https://www.prnewswire.co.uk/news-releases/oncoinvent-announces-first-patient-dosed-in-its-phase-2-clinical-trial-of-radspherin-in-ovarian-cancer-patients-302272777.html
